(Q44499100)

3 December 2017

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial (English)

1 reference

3 December 2017

1 reference

Hartmut Porst

1

1 reference

3 December 2017

Harin Padma-Nathan

2

1 reference

3 December 2017

François Giuliano

3

1 reference

3 December 2017

Greg Anglin

4

1 reference

3 December 2017

Lucio Varanese

5

1 reference

3 December 2017

Raymond Rosen

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

62

1 reference

3 December 2017

121-5; discussion 125-6

1 reference

3 December 2017

1

1 reference

The worldwide prevalence and epidemiology of erectile dysfunction

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Reports at European Urology Congress reflect issues of interest to aging men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Physician-patient dialogue and clinical evaluation of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Health outcomes variables important to patients in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900359-5

7 January 2021

10.1016/S0090-4295(03)00359-5

Identifiers

DOI

1 reference

3 December 2017

1 reference